- By Joy Hu
According to GuruFocus' Insider Data, this is the largest CEO buy during the past week. The overall trend of purchases is illustrated in the chart below:
-
Warning! GuruFocus has detected 3 Warning Signs with OPK. Click here to check it out.
-
The intrinsic value of OPK
OPKO Health Inc. (OPK) CEO, Chairman and 10% owner Phillip Frost bought 44,000 shares in four separate transactions last week.
Frost bought 12,000 shares for $8.67 per share on Jan. 27; 10,000 shares for $8.55 per share on Jan. 25; 10,000 shares for $8.46 per share on Jan. 24; and 12,000 shares for $8.48 per share on Jan. 23. He made five additional stock purchases earlier in January.
OPKO is a biopharmaceutical and diagnostics company. It is engaged in the research and development of pharmaceutical products and vaccines. The company has a market cap of $4.84 billion. As of Jan. 27 its shares traded at $8.69 with a price-earnings (P/E) ratio of 36.36.
Consolidated revenues for the three months ended Sept. 30, 2016 increased to $298.0 million from $143.0 million for the comparable period 2015. Net loss for the quarter was $15.0 million compared with net income of $128.2 million for the 2015 period.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.
Start a free seven-day trial of Premium Membership to GuruFocus.
This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 3 Warning Signs with OPK. Click here to check it out.
-
The intrinsic value of OPK